MacDermid Agrees To Go Private

Court Square Capital Partners and Weston Presidio have agreed to acquire Denver-based specialty chemical manufacturer MacDermid Inc. (NYSE: MRD) for $35 per share. The transaction is valued at over $1.3 billion, including assumption or repayment of approximately $301 million of debt. Company chairman and CEO Daniel Leever is participating alongside the equity sponsors, while Court Square managing partner Joseph Silvestri is a director of MacDermid and also is involved in the merger.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />